T-cell surface glycoprotein CD1b is a protein that in humans is encoded by the CD1B gene. CD1b belongs to group 1 of CD1 family of transmembrane glycoproteins. CD1 molecules are expressed on the surface of numerous different human antigen presenting cells. This specialised group of glycoproteins present self and non-self lipid-based antigens to specific αβ T-cells. CD1 molecules are structurally related to the major histocompatibility complex, belonging to MHC class I-like genes. The human CD1 locus is found on chromosome 1 and contains five nonpolymorphic genes.
CD1b molecules are formed by membrane-bound glycoprotein composed of three extracellular domains. These extracellular domains are non-covalently associated with β2 microglobulin. This organization forms a narrow hydrophobic binding groove that accommodates lipid-based antigens. The binding groove is made up of four broadly interconnected pockets that are occupied by the alkyl chains of glycolipid and two detergent molecules. Compared to other CD1 molecules this unique arrangement of CD1b provides the possibility of binding a wide spectrum of antigens with various lengths of alkyl chain. Alkyl components of antigens are attached in the hydrophobic groove and a hydrophilic part stands out from the CD1b molecule and thus provides to the TCR a place to bind. CD1b molecule has the largest antigen-binding cleft within the CD1 family. Whereas the microbial lipids tend to have longer alkyl chains than self endogeneous lipids it seems that CD1b is specifically adapted to present microbial lipids to T cells.
When the immune system does not distinguish self and non-self antigens, it leads to an autoreactive T-cell response. Autoreactive CD1b can recognize for example phospatidylglycerol, which is common for bacteria but also mammalian mitochodria. This autoantigen is released during a bacterial infection or mitochondrial stress. CD1b also presents endogenous gangliosides to specific T cells so they can commence autoimmune diseases such as multiple sclerosis. In contrast with major histocompatibility complexes, CD1 molecules have restricted diversity, it could be an interesting marker for imunotherapy and target for development of new drugs.
